| HOME >> BIOLOGY >> TECHNOLOGY |
2008 2007
(Unaudited) (Audited)
Current assets:
Cash and cash equivalents $10,280,130 $2,444,376
Short term investments 14,953,960 22,960,545
Interest receivable 46,186 102,518
Prepaid and other current assets 126,150 1,150
Total current assets 25,406,426 25,508,589
Investment in other ventures 189,066 186,790
Patents, net 529,226 550,834
Total assets $26,124,718 $26,246,213
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accrued expenses and other
current liabilities $108,853 $22,352
Total current liabilities 108,853 22,352
Commitments
Stockholders' equity:
Common stock 132,857 132,857
Additional paid-in capital 59,847,149 59,847,149
Accumulated deficit (33,664,066) (33,456,070)
Treasury stock (300,075) (300,075)
Total stockholders' equity 26,015,865 26,223,861
Total liabilities and
stockholder's equity $26,124,718 $26,246,213
CADUS CORPORATION
Condensed Consolidated Statements of Operations
Three Months Ended
March 31,
'/>"/>
| SOURCE Cadus Corporation Copyright©2008 PR Newswire. All rights reserved |